This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
An interesting conference has been held under the auspices of PCRI in Los Angeles. Reports from the conference, and other items of interest are on THE NEW PROSTATE CANCER INFOLINK
Here are some of the items:
-- Is some prostate cancer caused by “luminal” stem cells?
-- T. vaginalis and prostate cancer risk
-- Early penile rehabilitation seems to be “better”
-- Takeda to start Phase II trials of TAK-700
-- Prostate cancer news reports: Saturday, September 12, 2009 (including items on Screening and its impact on prostate cancer-specific mortality; Naproxen + calcitriol as first-line therapy for recurrent prostate cancer)
-- PCRI holds annual prostate cancer gathering
-- More evidence that deferring treatment can work just fine
-- “Something extraordinary” has happened in North Carolina
-- Radiation therapy in patients with +ve surgical margins
-- Adding hormone therapy to brachytherapy: what works best?
